Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference77 articles.
1. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity;Link;N Engl J Med,1986
2. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate;Meyers;J Clin Oncol,2005
3. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups;Ferrari;J Clin Oncol,2005
4. Management of osteosarcoma;Whelan;Curr Treat Options Oncol,2006
5. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial;Goorin;J Clin Oncol,2002
Cited by 186 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent advancement and trends in the development of membranes having bactericidal attributes via direct ink writing;Biomedical Materials;2024-08-01
2. The exposure to extremely low frequency electromagnetic-fields inhibits the growth and potentiates the sensitivity to chemotherapy of bidimensional and tridimensional human osteosarcoma models;Biomedicine & Pharmacotherapy;2024-08
3. High expression of DEC2 distinguishes chondroblastic osteosarcoma and promotes tumour growth by activating the VEGFC/VEGFR2 signalling pathway;Journal of Cellular and Molecular Medicine;2024-06
4. Osteosarcoma cell death induced by innovative scaffolds doped with chemotherapeutics;Journal of Cellular Physiology;2024-04-09
5. EphA2-specific microvesicles derived from tumor cells facilitate the targeted delivery of chemotherapeutic drugs for osteosarcoma therapy;Journal of Nanobiotechnology;2024-03-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3